Spla2 hydrolysable liposomes with improved storage stability

Active Publication Date: 2012-08-30
BIO BEDST
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0028]The composition improves storage stability of sPLA2 hydrolysable liposomes, in part

Problems solved by technology

The leakage problem was observed in relation to storage of cisplatin encapsulated in sPLA2 hydrolysable liposomes to be used for a phase 1 study of an iso-osmotic formulation of cisplatin encapsulated in sPLA2 hydrolysable liposomes.
Because of a high degree of leakage when stored 2-8 degrees Celsius, the iso-osmotic formulation had to be stored at minus 80 degrees Celsius, which is not an optimal solution for a commercial product.
Thus, not all hospitals have facilities for storage at minu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Spla2 hydrolysable liposomes with improved storage stability
  • Spla2 hydrolysable liposomes with improved storage stability
  • Spla2 hydrolysable liposomes with improved storage stability

Examples

Experimental program
Comparison scheme
Effect test

example 1

Optimization of Storage Stability of sPLA2 Hydrolysable Liposomes

[0159]Abstract

[0160]It has been observed that upon storage at 2-8° C. LiPlaCis (liposomal cisplatin) may have up to 30% leakage during the first couple of months. Leakage is most extensive during the first two months, and beyond this period only minor leakage occurs.

[0161]A factorial design was set up to test stability of LiPlacis at 2-8° C. Formulations were prepared with varying interior buffer composition, and homogenized at different pressures according to composite face design. 3 factors were tested at 3 levels:[0162]Interior NaCl concentration (0.9, 1.4, and 1.9%)[0163]Interior Sucrose concentration (0.5, and 10%)[0164]Homogenization pressure used during preparation (5000, 12500, and 20000 KPa).

[0165]Leakage from formulation was demonstrated to be influenced by all parameters tested. Increasing the sucrose and NaCl concentration on liposome interior and having low homogenization pressure during liposome preparation

example 2

[0199]Liposomal cisplatin formulations were prepared by film hydration followed by extrusion. Hydration solution was prepared with varying osmolyte concentrations. After extrusion the liposomes were dialyzed in different media. The formulations prepared had different osmotic gradient (difference in osmolarity between interior and exterior) as outlined in table 3. For comparison liposomal formulation of other chemotherapeutics were prepared as outlined in table 4. All Formulations were placed in refrigerator at 2-8° C., and samples were taken continually during storage.

[0200]Preparation of Liposomal Formulations

[0201]Phospholipids (DSPC / DSPG / DSPE-PEG2000, 70:25:5 mol %) were dissolved in 9:1 (v / v) chloroform / methanol. The solvent of the dissolved lipid mixtures were then evaporated in a 50° C. hot water bath until visual dryness, under a stream of nitrogen gas. The samples were further dried under vacuum overnight.

[0202]Hydration liquids (varying Salt and sucrose concentrations

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a composition comprising a sPLA2 hydrolysable liposome, an exterior solution, and an interior solution within the liposome, -wherein the concentration of osmolytes is higher in the interior solution than in the exterior solution. The composition improves storage stability of sPLA2 hydrolysable liposomes, in particular at when stored at 2-8 degrees Celsius. The liposome preferably encapsulates cisplatin. The invention also provides methods of preparing the composition of the invention.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner BIO BEDST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products